CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Shares withheld for taxes Executive Vice President gave up 117 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 279 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 1,097 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,839 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 283 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CHRO gave up 60 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 263 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Revenue Officer gave up 162 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 144 shares (to pay taxes)
- 4 Gift Director gave 5,350 shares (gift)
- 4 Open-market sale SVP, Chief Revenue Officer sold 8,198 shares at an average $573.87 ($4,704,559)
- 4 Gift Director gave 1,850 shares (gift)
- 4 Open-market sale EVP, CFO and Treasurer sold 23,326 shares at an average $570.01 ($13,295,975)
- 4 Open-market sale President and CEO sold 12,000 shares at an average $572.61 ($6,871,319)
- 4 Grant or award Director acquired 14 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Executive Vice President sold 11,636 shares at an average $521.79 ($6,071,500)
- 4 Open-market sale President and CEO sold 7,128 shares at an average $513.05 ($3,657,049)
Page 7 of 74 · 1,467 filings